Annexon Biosciences takes in $75 mln Series C

South San Francisco-based Annexon Biosciences, a biopharmaceutical company, has raised $75 million in Series C financing. Bain Capital Life Sciences led the round with participation from Surveyor Capital, Adage Capital Partners, New Enterprise Associates, Blackstone Life Sciences, Novartis Venture Fund and Satter Investment Management.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!